Evicenter
P&T meetings

SKY-0515

Huntington's disease

Last updated
211 sources

Product information and disease descriptionProduct descriptionProduct information

Access and distribution

3 evidence topics · 3 sources

Current access through clinical trials only

“SKY-0515 is an investigational, once-daily oral medicine that is currently only available through clinical trials.” (opens the source at this quote in a new tab)

Continued access for trial completers

“Treatment Duration: until drug becomes commercially available or until the development of SKY-0515 is terminated by the Sponsor.” (opens the source at this quote in a new tab)

Commercial preparation

“I'm thrilled to join the company to prepare for the launch of SKY-0515 and to help ensure the broadest number of patients can access this important therapy.” (opens the source at this quote in a new tab)

Expanded access program, specialty distribution, and REMS

No evidence found.